News

Top
News
Kyorin Pharmaceutical and Kaken Pharmaceutical signed a Contract for the co-promotion of the anti-allergic therapeutic agent "desloratadine"

Kyorin Pharmaceutical and Kaken Pharmaceutical signed a Contract for the co-promotion of the anti-allergic therapeutic agent "desloratadine"

July 11, 2016

Please see the PDF file below for details.

Kyorin Pharmaceutical and Kaken Pharmaceutical signed a Contract for the co-promotion of the anti-allergic therapeutic agent "desloratadine" [ 71.0 KB ]